These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35997471)

  • 1. Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.
    Fukasawa LO; Liphaus BL; Gonçalves MG; Higa FT; Camargo CH; Carvalhanas TRMP; Lemos APS
    Emerg Infect Dis; 2022 Sep; 28(9):1931-1932. PubMed ID: 35997471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
    Micoli F; Romano MR; Tontini M; Cappelletti E; Gavini M; Proietti D; Rondini S; Swennen E; Santini L; Filippini S; Balocchi C; Adamo R; Pluschke G; Norheim G; Pollard A; Saul A; Rappuoli R; MacLennan CA; Berti F; Costantino P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19077-82. PubMed ID: 24191022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
    Hong E; Giuliani MM; Deghmane AE; Comanducci M; Brunelli B; Dull P; Pizza M; Taha MK
    Vaccine; 2013 Feb; 31(7):1113-6. PubMed ID: 23261039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.
    de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G
    Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
    Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
    Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.
    Subbarao S; Campbell H; Ribeiro S; Clark SA; Lucidarme J; Ramsay M; Borrow R; Ladhani S
    Emerg Infect Dis; 2021 Sep; 27(9):2495-2497. PubMed ID: 34193335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccines in China.
    Xu Y; Li Y; Wang S; Li M; Xu M; Ye Q
    Hum Vaccin Immunother; 2021 Jul; 17(7):2197-2204. PubMed ID: 33566720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.
    Taha MK; Presa J; Serra L
    Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic.
    Brynildsrud OB; Watle SV; Alfsnes K; Caugant DA
    Int J Infect Dis; 2023 Jun; 131():130-139. PubMed ID: 37030654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for eradication of meningococcal disease.
    Nadel S
    Arch Dis Child; 2012 Nov; 97(11):993-8. PubMed ID: 22984187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 15. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
    Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic's influence on parents' attitudes and behaviors toward meningococcal vaccination.
    Tan LLJ; Safadi MAP; Horn M; Regojo Balboa C; Moya E; Schanbaum J; Pimenta P; Lambert E; Soumahoro L; Sohn WY; Bruce T; Ruiz García Y
    Hum Vaccin Immunother; 2023 Dec; 19(1):2179840. PubMed ID: 36883777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007-2019).
    Feijo RB; Cunha J
    Braz J Infect Dis; 2020; 24(4):349-351. PubMed ID: 32659221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
    PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.